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Within secondary lymphoid tissues, stromal reticular
cells support lymphocyte function, and targeting
reticular cells is a potential strategy for controlling
pathogenic lymphocytes in disease. However, the
mechanisms that regulate reticular cell function are
not well understood. Here we found that during an
immune response in lymph nodes, dendritic cells
(DCs) maintain reticular cell survival in multiple com-
partments. DC-derived lymphotoxin beta receptor
(LTbR) ligands were critical mediators, and LTbR
signaling on reticular cells mediated cell survival by
modulating podoplanin (PDPN). PDPNmodulated in-
tegrin-mediated cell adhesion, which maintained cell
survival. This DC-stromal axis maintained lympho-
cyte survival and the ongoing immune response.
Our findings provide insight into the functions of
DCs, LTbR, and PDPN and delineate a DC-stromal
axis that can potentially be targeted in autoimmune
or lymphoproliferative diseases.
INTRODUCTION
Within lymph nodes, lymphocytes are supported by a non-
hematopoietic vascular-stromal compartment that modulates
lymphocyte survival, localization, and function (Cyster, 2005;
Malhotra et al., 2013). Manipulating this compartment could be
a means for controlling pathologic lymphocytes in autoimmune
or lymphoproliferative diseases. As lymph nodes enlarge
with stimulation, stromal reticular cells undergo a proliferative
expansion (Chyou et al., 2011; Yang et al., 2014). Although initial
proliferation and immune activation can potentially be targeted,
patients with chronic immune diseases are likely to display
ongoing responses. Understanding how reticular cells are main-
tained in already-enlarged nodes, then, can lead to the develop-
ment of more effective therapeutic strategies.
Defined reticular cell populations in lymph nodes share the
marker podoplanin (PDPN; also known as gp38) but servedistinct functions in each compartment. These cells are some-
times referred to as ‘‘fibroblastic reticular cells’’ (FRCs), although
this term has been variably applied to all or different subpopula-
tions (Chyou et al., 2011; Cremasco et al., 2014; Yang et al.,
2014). Herein, we will use the descriptive term ‘‘PDPN+ reticular
cells’’ and refer to specific subsets when applicable. In the T
zone, PDPN+ reticular cells generate and ensheathe a network
of collagen-rich fibrils, and the resulting reticular network facili-
tates T cell-dendritic cell (DC) interactions (Baje´noff et al.,
2006; Malhotra et al., 2013). PDPN+ reticular cells also express
interleukin-7 (IL-7), which is required for naive T cell survival
and CCL19 and CCL21, which compartmentalize T cells and
DCs in the T zone (Cyster, 2005; Link et al., 2007). In contrast,
B follicle reticular cells express CXCL13, which is required for
B cell compartmentalization (Cyster, 2005; Katakai et al., 2008;
Mionnet et al., 2013). CXCL13-expressing cells include follicular
dendritic cells (FDCs) that present antigen to B cells, PDPN+
marginal reticular cells (MRCs) that extend from the subcapsular
sinus, and in secondary follicles, PDPN+ reticular cells in the
mantle zone at the border of the T and B zones. Mantle-zone
PDPN+ cells express BAFF (TNFSF13B), which supports naive
B cell survival, and BAFF is also expressed in FDCs, where it
can support germinal-center responses (Cremasco et al.,
2014; Hase et al., 2004; Suzuki et al., 2010). In the medulla,
PDPN+ reticular cells presumably express CCL21 at low concen-
trations and CXCL12, which facilitates accumulation of plasma-
blasts and plasma cells (herein referred to collectively as ‘‘anti-
body-forming cells,’’ [AFCs]) (Bannard et al., 2013; Braun et al.,
2011; Hargreaves et al., 2001; Yang et al., 2014). CXCL12 might
also promote AFC survival, and PDPN+ cells can express inter-
leukin-6 (IL-6), APRIL (TNFSF13), and other cytokines that might
additionally contribute to AFC survival (Malhotra et al., 2013;
Mohr et al., 2009). Directly depleting PDPN+ reticular cells
disrupts lymphocyte survival and ongoing immune responses
(Cremasco et al., 2014; Denton et al., 2014), underscoring the
potential utility of delineating reticular cell survival mechanisms.
The regulation of PDPN+ reticular cell survival during ongoing
immune responses is poorly understood. Endothelial and retic-
ular cell proliferation begins within 2 days after immunization
(Chyou et al., 2011; Yang et al., 2014). After immunization with
ovalbumin (OVA) in complete Freund’s adjuvant (CFA) orImmunity 42, 719–730, April 21, 2015 ª2015 Elsevier Inc. 719
stimulation with bone-marrow-derived dendritic cells, endothe-
lial cell proliferation peaks on day 5 and is subsequently downre-
gulated while endothelial cell numbers are maintained or
continue to expand for at least another week. (Tzeng et al.,
2010). The re-establishment of vascular quiescence is depen-
dent on late-accumulating CD11chi cells presumed to be DCs
(Tzeng et al., 2010). CD11chi cells are closely associated with
perivascular reticular cells and maintain their tight organization
around vessels, suggesting that late-accumulating DCsmaintain
aspects of reticular cell function. The re-establishment of
vascular quiescence after day 5 parallels the development of
germinal centers and AFCs, suggesting that understanding
how DCs might regulate reticular cells throughout the lymph
node could be helpful for manipulating ongoing immune
responses.
Here we found that during the re-establishment of quiescence,
DCs maintained reticular cell survival in multiple lymph node
compartments. DC-derived lymphotoxin b receptor (LTbR) li-
gands were critical mediators of this effect, and the importance
of these cell-associated ligands, the DC localization pattern, and
the effect of DCs on reticular cell survival in vitro suggested that
DCs act directly on reticular cells. LTbR signaling on reticular
cells promoted survival by modulating PDPN, and PDPN
signaling modulated integrin-mediated cell adhesion. In vivo,
the effects of DCs, PDPN, and cell adhesion were observed dur-
ing the re-establishment of quiescence but not during homeo-
stasis, suggesting that this DC-stromal axis is specific to an
inflamed environment. This axis maintained lymphocyte survival
and the ongoing response. Together, our results identify new
functions for DCs, LTbR, and PDPN in mediating reticular cell
survival and establish a novel DC-stromal axis that can poten-
tially be targeted in chronic immune diseases.
RESULTS
Non-T, Non-B CD11c+ Cells Localize with PDPN+ Cells in
Multiple Compartments
To examine the effects of DCs on reticular cells in the context of
robust B cell responses, we immunized mice with alum-precipi-
tated OVA (OVA-Alum). Lymph node cellularity had increased by
day 2 and was maximal by day 9 (Figure S1A). Similar to results
obtained with other immunization strategies (Tzeng et al., 2010),
endothelial cells showed peak proliferation on day 5 and relative
quiescence on day 9 alongwith expanded numbers (Figure S1B–
S1D). PDPN+ reticular cells showed similar proliferation and
growth dynamics (Figure S1E–S1F), suggesting that the entire
vascular-stromal compartment undergoes re-establishment of
quiescence after day 5.
PDPN on reticular cells was upregulated over time (Fig-
ure S1G), andCD11c+ cells also accumulated. CD11chiMHCIImed
(CD11chi) cells are presumed to be resident DCs,CD11c+MHCIIhi
(MHCIIhi) cells include DCs recruited from skin and blood, and
CD11cmedMHCIImed (CD11cmed) cells include monocytes, mac-
rophages, plasmacytoid DCs, and inflammatory DCs (Merad
et al., 2013; Tzeng et al., 2010). CD11cmed and MHCIIhi cells
were highly enriched by day 2 (Figures S1H and S1I), reflecting
the rapid accumulation of interleukin-1b-expressing monocytes
and MHCIIhi DCs that can help drive early vascular-stromal pro-
liferation (Benahmed et al., 2014). MHCIIhi DCs remained en-720 Immunity 42, 719–730, April 21, 2015 ª2015 Elsevier Inc.riched on day 9 but had a less activated phenotype, with reduced
MHCII and CD11b expression (Figures S1H and S1I and data not
shown). CD11chi cells, in contrast to the other populations, accu-
mulated more slowly; the greatest enrichment occurred on day 9
(Figure S1H and S1I). Re-establishment of vascular-stromal
quiescence, then, was associated with high reticular cell PDPN
and maximal accumulation of CD11chi DCs.
To study the localization and function of non-T, non-B CD11c+
cells (Baumjohann et al., 2013; Jung et al., 2002; Tzeng et al.,
2010), we generated Cd11c-DTRRag1/ mixed chimeras
whereby lethally irradiated wild-type (WT) recipients were recon-
stituted with 80%Cd11c-DTRRag1/ and 20%WTbonemarrow
(Figure S2). In these chimeras, non-T, non-B CD11c+ cells were
marked by the expression of the DTR-EGFP fusion protein, At
day 9 after immunization, EGFP+ cells were found throughout
the T zone and also in B cell areas (Figures 1A and 1B). In the
T zone, EGFP+ cells were closely associated with the network
of PDPN+ cells and fibrils marked by ER-TR7 antibody (Fig-
ure 1C). In secondary follicles, EGFP+ cells were located within
the mantle zone at the T-B border, where they were associated
with PDPN+ cells (Figures 1D and 1E). EGFP+ cells were also
located in other areas of the mantle zone and within germinal
centers (Figure 1D). Consistent with findings from CD11c
staining (Mohr et al., 2009; Tzeng et al., 2010), EGFP+ cells
also localized within the medullary cords with CD138+ AFCs
(Figure 1F) and were associated with PDPN+ reticular cells (Fig-
ure 1F). Together, these chimeras suggested that non-T, non-B
CD11c+ cells were associated with PDPN+ reticular cells in
multiple compartments.
Non-T, Non-B CD11c+ Cells Maintain Reticular Cell
Numbers and the Ongoing Immune Response
Diphtheria toxin (DT) treatment of the Cd11c-DTRRag1/ chi-
meras depleted CD11chi cells by 80% andMHCIIhi DCs by about
50% (Figure 2A). Blood endothelial cell ICAM-1 was upregulated
(Figure S3A), consistent with previous findings (Tzeng et al.,
2010). PDPN+ reticular cell numbers were partially reduced
without a concomitant increase in PDPN reticular cells (Fig-
ure 2B), suggesting the possibility of disrupted PDPN+ reticular
cell survival. CD11c+ cell depletion also reduced lymph node
cellularity and the numbers of total B and T cells, germinal center
B cells, and IgG+ AFCs (Figures 2C–2E). Activated CD4+ T cell
percentages and regulatory T cell percentages were not altered
(Figures S3B and S3C). CD11c+ cell depletion reduced lympho-
cyte numbers even upon blockade of lymph node entry and exit
(Figure S3D), suggesting that lymphocyte loss was due to
compromised survival. We did not detect more AFCs in the
blood circulation or bone marrow (Figure S3E), suggesting that
the AFC loss was due not to lymph node egress but to disrupted
AFC survival. These results together suggested that CD11c+
cells maintain PDPN+ reticular cell numbers and the ongoing
immune response.
Classical DCs Maintain Reticular Cell Survival and the
Ongoing Immune Response
To understand whether the effects of CD11c+ cell depletion pri-
marily reflected the depletion of DCs, we used Zbtb46-EGFP re-
porter mice and zDC-DTR mice that express diphtheria toxin
receptor in Zbtb46-expressing cells. Zbtb46 is a transcription
Figure 1. Non-T, Non-B CD11c+ Cells
Localize with PDPN+ Cells in Multiple
Compartments
Cd11c-DTRRag1/ mixed chimeras were immu-
nized in footpads with OVA-alum on day 0, and
draining popliteal nodes were taken on day 9.
Sections were stained for the DTR-EGFP fusion
protein and other indicated markers. (A and B)
Nearby sections from the same lymph node
showing EGFP+ cell localization relative to (A)
T cells and (B) B cells and PDPN+ cells. F = follicle.
(C–F) EGFP+ cell localization in the (C) T zone, (D)
follicles (GC = germinal center), (E) follicularmantle
zone, and (F) medulla. Results are representative
of at least three lymph nodes. (A, B, D, and F) The
scale bar represents 100 mm. (C and E) The scale
bar represents 50 mm. See also Figures S1 and S2.factor also expressed by endothelial cells, and it distinguishes
classical Flt3-dependent DCs from monocytes and monocyte-
derived cells (Meredith et al., 2012; Satpathy et al., 2012).
Zbtb46-EGFP mice (Satpathy et al., 2012) confirmed DC locali-
zation in the T zone, within the mantle zone at the T-B boundary,
and more sparsely in the rest of the mantle zone and in germinal
centers (Figure S4A). To deplete DCswithout depleting endothe-
lial cells, we generated zDC-DTR/WT chimeras. Similar to
CD11c+ cell depletion, DT treatment of these chimeras depleted
the vast majority of CD11chi cells and partially depleted the
MHCIIhi population (Figure 3A). CD11cmed cells were also
partially depleted (Figure 3A). As with CD11c+ cell depletion,
DC depletion reduced PDPN+ reticular cell numbers without
increasing PDPN cells (Figure 3B). PDPN+ reticular cell loss
was accompanied by an increased percentage of TUNEL+ cells
(Figure 3C), suggesting that the cell loss was due to disrupted
survival. To understand whether DC depletion disrupted reticular
cell survival in multiple compartments, we stained reticular cells
intracellularly for CCL21 to identify T zone and medullary cells
and for CXCL13 to identify follicular cells (Figure S4B).
CCL21CXCL13 cells that most likely included medullary cells
were calculated by subtracting CCL21+ and CXCL13+ cell
numbers from total PDPN+ cell numbers. Such subsetting
showed that CCL21+ cells comprised the largest subpopulation
on day 9 (Figure S4B). FDCs were identified by CD35 staining
and were both PDPN+ and PDPN (Figure S4C) (Jarjour et al.,
2014; Link et al., 2007). PDPN+ FDCs were partially CXCL13+
and partially CCL21+ (Cremasco et al., 2014; Wang et al.,
2011) and comprised 20%–35% of each PDPN+ subpopulation
(Figure S4C). Upon DC depletion, each of the PDPN+ CCL21+,
CXCL13+, CCL21CXCL13 subpopulations was reduced in
number (Figure 3D), whereas the proportions of CD35+ cellsImmunity 42, 719–7(i.e., FDCs) and CD35 cells in each sub-
population stayed constant (Figure S4C).
This suggested that reticular cells in the T
zone, follicular mantle, and medulla along
with PDPN+ FDCs were lost with DC
depletion. Total (PDPN+ and PDPN)
FDCs were also reduced in number (Fig-
ure 3D). These results suggested that
DCs maintain the survival of PDPN+ retic-ular cells in the T zone, follicular mantle, and medulla and of
FDCs in germinal centers.
DC depletion also reduced the numbers of B and T cells,
germinal center B cells, and AFCs (Figures 3E and 3F). Lympho-
cyte staining by TUNEL (terminal deoxynucleotidyl transferase
dUTP nick-end labeling) was increased (Figure 3G), supporting
the idea of disrupted lymphocyte survival. Morphologically, folli-
cles with germinal centers were present (Figure S4D), although
the number of germinal centers was reduced (Figure 3H).
Numbers of activated caspase 3+ cells were increased (Fig-
ure S4E), suggesting disrupted germinal-center B cell survival.
There was greater mixing of CD8+ T cells with IgD+ B cells at
the T-B border (Figure 3I and Figure S4F), suggesting that retic-
ular cells in this region were among the mantle-zone cells lost.
DC depletion during homeostasis did not affect PDPN+ reticular
or lymph node cell numbers (Figure S4G). These results indi-
cated that classical DCs maintain reticular cell survival, integrity
of lymph node compartments, and the ongoing immune
response in stimulated lymph nodes.
CD11c+ Cells Maintain Stromal-Derived Lymphocyte
Survival-Factor Expression
The disrupted lymphocyte survival associated with DC deple-
tion led us to ask about survival-factor expression. B cells in
CD11c+-cell-depleted nodes had higher expression of the
BAFF receptor (Figure 4A), suggesting reduced BAFF availabil-
ity (Lesley et al., 2004). PDPN+ reticular cells on day 9 ex-
pressed high amounts of BAFF, IL-6, and IL-7 relative to
amounts expressed by other vascular-stromal cells and to
CD11c+ cells (Figures 4B and 4C). Upon CD11c+ cell depletion,
amounts of PDPN+ reticular cell BAFF, IL-6, and IL-7 were all
reduced (Figure 4D), consistent with the loss of reticular cells30, April 21, 2015 ª2015 Elsevier Inc. 721
Figure 2. Non-T, Non-B CD11c+ Cells Maintain PDPN+ Reticular Cells and the Ongoing Immune Response
Cd11cDTRRag1/ mixed chimeras were immunized on day 0, treated with PBS or DT on day 8, and examined on day 9.
(A) CD11c+ cell numbers. Left: representative flow-cytometry plots. Right: absolute and relative numbers.
(B and C) Absolute and relative numbers of (B) PDPN+ and PDPN reticular cells and (C) total, B220+ B, and CD3+ T cells.
(D and E) Left: representative flow-cytometry plots. Right: absolute and relative numbers of (D) germinal-center B cells and (E) AFCs.
Data were pooled from 3–4 independent experiments. Each point represents onemouse; error bars represent SD. ** p < .01 in an unpaired t test comparing DT to
PBS samples. See also Figure S3.in multiple compartments. These results suggested that DC
depletion led to reduced stromal expression of lymphocyte sur-
vival factors; along with a loss of DC-derived survival factors
(Mohr et al., 2009), this reduced expression contributed to
disruption of the immune response.
DC-Derived LTbR Ligands Maintain Reticular Cells
LTbR can modulate stromal function, and lymph node CD11c+
cells can express LTbR ligands (Boulianne et al., 2012; Lu and
Browning, 2014; Moussion and Girard, 2011; Zhu et al., 2011).
LTbR-Ig reduced PDPN+ reticular cell numbers (Figure 5A), sug-
gesting that DCs could maintain reticular cell survival via LTbR722 Immunity 42, 719–730, April 21, 2015 ª2015 Elsevier Inc.ligands a1b2 and LIGHT (TNFSF14). CD11c+ cells expressed
less LTa and LTb than did unfractionated lymph node cells (Fig-
ure 5B), reinforcing the idea that lymphocytes are major sources
of LTa1b2 (Junt et al., 2006) but not excluding the potential
importance of DC-derived LTa1b2. CD11c+ cells, on the other
hand, expressed more LIGHT than unfractionated lymph nodes
(Figure 5B). We tested the importance of DC-derived LTa1b2
and LIGHT by reconstituting wild-type mice with a mix of
zDC-DTR and WT bone marrow or substituted the WT bone
marrow with Ltb/Rag1/ or Tnfsf14/Rag1/ bone marrow
(Figure S5A). All T and B cells in these chimeras were LTb- or
LIGHT-sufficient, and DT treatment on day 8 after immunization
Figure 3. Classical DCs Maintain Reticular Cell Survival and the Ongoing Immune Response
zDC-DTR chimeras were immunized on day 0, injected with PBS or DT on day 8, and examined on day 9.
(A) CD11c+ cell numbers. Data were pooled from three experiments.
(B) PDPN+ and PDPN reticular cell numbers. Data were pooled from four experiments.
(C) PDPN+ reticular cell TUNEL staining, expressed as a percentage of PDPN+ reticular cells that are TUNEL+. Data were pooled from two experiments.
(D) Reticular cell subpopulation numbers. Left: normalized numbers of indicated PDPN+ reticular cell subsets. Data are from four experiments. Right: normalized
numbers of total (PDPN+ and PDPN) CD35+ cells. Data are from two experiments.
(E and F) B and T cell (E) and germinal-center B cell and AFC (F) numbers. Data are from three experiments.
(G) TUNEL staining in B220+ B cells and (CD45+) Thy1+ T cells. Data were pooled from two experiments.
(H) Number of germinal centers per tissue section. Data were pooled from three experiments.
(I) Compartmental integrity. Representative of at least three pairs of mice. The white bar represents 100 mm. For (A–H), each symbol represents one mouse; error
bars represent SD. *p < .05 and **p < .01 in an unpaired t test comparing DT and PBS samples. See also Figure S4.resulted in DCs that had relative LTb or LIGHT deficiency in
the experimental groups (Figure S5B). Lymph node cellularity
was similar across groups before depletion, and reticular cell
numbers were actually greater in LTb-deficient chimeras (Fig-
ures S5C and S5D), but DT treatment reduced total numbers
of PDPN+ reticular cells specifically in the LTb- and LIGHT-defi-
cient chimeras (Figure 5C). LTb deficiency affected each of the
CCL21+, CXCL13+, and CCL21CXCL13 subpopulations (Fig-
ure 5C). The reduction in the LIGHT-deficient chimeras wasmore variable and reached statistical significance only in the
CCL21CXL13 subset (Figure 5C). These results suggest that
both DC-derived LTa1b2 and LIGHT maintain PDPN+ reticular
cell survival.
In vitro, CD11c+ cells maintained the survival of serum-starved
PDPN+ reticular cells (Figure S5E, left and middle). This effect
was blocked by LTbR-Ig (Figure S5E, left and middle), further
supporting the concept that DCs express LTbR ligands to
maintain reticular cell survival.Immunity 42, 719–730, April 21, 2015 ª2015 Elsevier Inc. 723
Figure 4. CD11c+ Cell Depletion Reduces
Stromal Expression of Lymphocyte Survival
Factors
Mice were immunized on day 0 and treated or ex-
amined at indicated time points after immuniza-
tion.
(A) B cell BAFF receptor expression in
Cd11cDTRRag1/ chimeras given PBS or DT on
day 8 and examined on day 9. Data are repre-
sentative of three pairs of mice from two experi-
ments.
(B and C) Expression of BAFF, IL-6, and IL-7 by (B)
vascular-stromal and (C) CD11c+ cell subsets.
Indicated populations were sorted from (B) day 9
or (C) day 8 draining nodes, and cytokine
expression was evaluated by qPCR. ‘‘Whole
lymph node’’ indicates collagenase-digested
lymph node cells prior to cell separation. Note
differences in scale in (B) and (C). Data were
pooled from (B) four and (C) three independent
experiments.
(D) Cytokine expression by PDPN+ reticular cells
on day 9 after CD11c+ cell depletion on day 8 in
CD11c-DTR mice. Data were pooled from three
independent experiments.
For (B–D), each symbol represents one sample
sorted from (B and D) 6–8 mice or (C) 4–5 mice.
*p < .05 and **p < .01 in an unpaired t test
comparing the indicated cells with controls or as
indicated. Error bars represent SD.PDPNMaintains Reticular Cell Survival and the Ongoing
Immune Response
We noted a drop in reticular cell PDPN expression upon DC
depletion (Figure 6A), and a drop was detectable as early as
5.5–8 hr after DT injection in association with increased
apoptosis (Figure S6A). In vitro, CD11c+ cells induced PDPN up-
regulation, which was blocked by LTbR-Ig (Figure S5E, right).
These data suggest the possibility that DCs modulated PDPN
to maintain reticular cell survival.
We asked whether PDPN mediated reticular cell survival by
treating mice with PDPN-targeted siRNA on days 6 and 7 after
immunization and analyzing results on day 9. In initial experi-
ments involving labeled siRNA, about 30% of PDPN+ reticular
cells in draining nodes were labeled, whereas only 5% of cells
were labeled in non-draining nodes (data not shown), potentially
reflecting differential blood flow. By day 9, PDPN-targeted siRNA
had reduced PDPN+ reticular cell numbers (Figure 6B) and
increased TUNEL staining (Figure 6C). As occurred after DC
depletion, CCL21+, CXCL13+, and CCL21CXCL13 popula-724 Immunity 42, 719–730, April 21, 2015 ª2015 Elsevier Inc.tions and total numbers of FDCs were
reduced upon PDPN targeting (Fig-
ure 6D). These results suggested that
PDPN maintained reticular cell survival
in immunized nodes.
PDPN targeting also reduced B and
T cell, germinal center B cell, and AFC
numbers (Figures 6E and 6F) and
increased lymphocyte TUNEL staining
(Figure 6G). Germinal centers were fewer
in number, and CD8+ T cells and IgD+ Bcells mixed at the T-B boundary (Figures S6B and S6C). PDPN+
reticular cells expressed less BAFF and IL-7 upon PDPN knock-
down (Figure 6H). These results suggest that, similar toDCdeple-
tion, PDPNknockdowndisrupted theongoing immune response,
potentially by disrupting reticular cell survival and reducing
lymphocyte survival-factor expression.
Because PDPN is also expressed on lymphatic endothelial
cells and myeloid cells (Astarita et al., 2012; Schacht et al.,
2003), we asked whether PDPN on reticular cells directly modu-
lated cell survival. PDPN knockdown in cultured reticular cells
reduced cell numbers (Figure 6I) and increased annexin V stain-
ing (Figure 6J), echoing the increased apoptosis seen in vivo. In
serum-starved cultures, agonist anti-LTbR treatment increased
PDPN expression and cell numbers (Figure 6K). However,
PDPN knockdown prevented the increase in cell numbers (Fig-
ure 6K), supporting the idea that DC-derived LTbR ligands
mediate reticular cell survival via PDPN.
We next examined how PDPN mediated cell survival. PDPN
activates Rho GTPases and modulates phosphorylation of the
Figure 5. DC-Derived LTbR Ligands Maintain Reticular Cells
Mice were immunized on day 0 and treated or examined at the indicated time points after immunization.
(A) PDPN+ and PDPN reticular cell numbers in mice treated with LTbR-Ig on day 8 and examined on day 9. Data were pooled from two experiments.
(B) LTbR ligand mRNA expression by ‘‘whole’’ unsorted lymph node cells and the indicated CD11c+ cell subsets on day 8. Data are from three experiments.
(C) Role of DC-derived LTbR ligands. zDC-DTR: WT, LTb-, or LIGHT-deficient mixed chimeras were immunized on day 0 and given PBS or DT on day 8, and
reticular cell subset numbers were analyzed on day 9. Data are from three separate experiments for both LTb- and LIGHT-deficient chimeras.
For (A and C), each symbol represents onemouse. For (B), each symbol represents one sample sorted from 4–5 pooledmice. *p < .05 and **p < .01 in an unpaired
t test comparing the indicated samples. Error bars indicate SD. See also Figure S5.ezrin, radixin, moesin (ERM) family of cytoplasmic signaling pro-
teins that link membrane receptors to the cytoskeleton (Acton
et al., 2014; Astarita et al., 2015; Martı´n-Villar et al., 2006). This
signaling was recently found tomediate cell contractility in lymph
node reticular cells (Acton et al., 2014; Astarita et al., 2015).
Consistent with this PDPN signaling pathway, PDPN knockdown
reduced the amount of phosphorylated ERM (pERM) (Figure 6L).
The extracellular domain of PDPN can associate with a number
of cell-surface molecules, and this domain might be key for
mediating ERM phosphorylation (Astarita et al., 2012; Astarita
et al., 2015); adding PDPN-Fc to disrupt PDPN interactions
with other membrane proteins also resulted in reduced cell
numbers and pERM (Figure S6D). CLEC-2 on DCs can bind
PDPN and act as an antagonist (Acton et al., 2014; Astarita
et al., 2015), but CLEC-2-Fc effects can be transient in vitro (Ac-
ton et al., 2014) and had not influenced cell numbers by 48 hr af-
ter CLEC2-Fc treatment (Figure S6E). In vivo, DC depletion
reduced reticular cell pERM (Figure S6F). ERM phosphorylation
and cell contraction downstream of PDPN are blocked in vitro by
the Rho kinase (ROCK) inhibitor Y27632 (Acton et al., 2014;
Astarita et al., 2015; Martı´n-Villar et al., 2006), and Y27632 also
disrupted cell survival (Figure 6M). Together, these results sug-
gest that PDPN mediates reticular cell survival via the same
Rho-ROCK-ERM pathway that mediates cell contractility.
Cell contractility is linked to cell-matrix adhesion, which can
modulate cell survival (Geiger et al., 2009). PDPN is a positive
regulator of cell adhesion (Astarita et al., 2015; Schacht et al.,
2003), and PDPN knockdown reduced cell adhesion (Figure 6N).Blocking b1 integrins reduced cell survival (Figure 6O), suggest-
ing that cell-matrix adhesion was important for cell survival in
our system. Focal adhesion kinase (FAK) phosphorylated at
Y397 is a major transducer of integrin-mediated cell-survival
signals (Mitra and Schlaepfer, 2006), and PDPN knockdown
reduced pFAK phosphorylation at Y397 (Figure 6P). Similar to
PDPN knockdown, anti-PDPN reduced cell survival and
amounts of phospho-FAK (pFAK) (Figure S6G). ROCK inhibition
also reduced pFAK amounts (Figure 6Q), establishing linked
regulation of contractility and adhesion in these cells. In vivo,
DC depletion reduced amounts of pFAK (Figure S6H). Together,
these results suggested that PDPN mediates cell survival at
least in part via Rho and modulation of integrin-mediated cell
adhesion.
Consistent with the in vivo PDPN-knockdown results, admin-
istration of anti-PDPN on day 8 after immunization had reduced
reticular cell numbers by day 9 (Figure S6I). In contrast, anti-
PDPN in homeostatic mice for 24 hr did not reduce cell numbers
(Figure S6I), echoing the recent finding that anti-PDPN for 48 hr
during homeostasis increases reticular cell proliferation (Astarita
et al., 2015). These results suggested that PDPN plays different
roles in homeostatic and stimulated lymph nodes. We asked
whether these context-dependent differences could be related
to differences in cell adhesion. pFAK was upregulated along
with PDPN by day 9 after immunization (Figure 6R and Fig-
ure S1G), suggesting upregulation of cell adhesion. Cell-adhe-
sion upregulation can be a survival mechanism in that it counters
the pro-apoptotic effects of TNFa or other insults (Fornaro et al.,Immunity 42, 719–730, April 21, 2015 ª2015 Elsevier Inc. 725
Figure 6. PDPN on Reticular Cells Is Regulated by DCs and Maintains Cell Survival
(A) PDPN expression on PDPN+ reticular cells in zDC-DTR chimeras 24 hr after DC depletion. Left: representative flow-cytometry plots. Right: pooled analysis of
PDPN geometric mean fluorescence intensity from five experiments.
(B–H) Mice were immunized on day 0 and injected with control or indicated PDPN-targeted siRNAs (PDPN #1 or PDPN #2) on days 6 and 7, and draining popliteal
nodes were examined on day 9. (B) PDPN+ and PDPN reticular cell numbers. Data were pooled from at least three experiments. (C) PDPN+ reticular cell TUNEL
expression. Data were pooled from two experiments. (D) Relative numbers of indicated subsets of PDPN+ reticular cells and of total (PDPN+ and PDPN) CD35+
cells. Data were pooled from two experiments. (E and F) Relative numbers of (E) total, B, and T cells and (F) germinal-center B cells and AFCs. Data are from at
least three experiments. (G) B and T cell TUNEL staining. Data are from two experiments. (H) mRNA expression of the indicated cytokines by sorted PDPN+
reticular cells. Each symbol represents one sample sorted from eight mice; there was one sample per condition per experiment.
(I–L) Cultured PDPN+ reticular cells were transfected with control, PDPN#1, or PDPN#2 siRNA. (I) Left: histograms showing the extent of PDPN knockdown. Right:
relative cell counts of live gated cells 48–72 hr after transfection. Data were pooled from four experiments; there was one well per condition per experiment. (J)
(legend continued on next page)
726 Immunity 42, 719–730, April 21, 2015 ª2015 Elsevier Inc.
Figure 7. Disrupted Immune Responses after DC Depletion Can Be Rescued by Administration of Survival Factors or Stimulation with LTbR
(A and B) BAFF and IL-7 administration. zDC-DTR chimeras were given PBS or DT on day 8 after immunization and the indicated cytokine 5–8 hr after PBS or DT
administration. Mice were examined 20–24 hr after cytokine injection. The numbers of cells in the indicated populations were normalized and compared to ‘‘DT +
PBS’’ numbers. (A) Total, B, and T cell numbers. (B) Germinal-center B cell and AFC numbers. Data are from four experiments.
(C–F) LTbR stimulation. The experimental setupwas the same as in (A andB) except that zDC-DTR chimeras received control goat Ig or agonist anti-LTbRafter DT
administration. The numbers of indicated populations were normalized and compared to ‘‘DT + goat Ig’’ numbers. (C) PDPN+ reticular cells. (D) Total, B, and
T cells. (E) Germinal-center B cells and AFCs. (F) CD11c+ cell subsets. Data are from four experiments
Each symbol represents one mouse. *p < .05 and **p < .01 in an unpaired t test comparing mice to the indicated controls. Error bars indicate SD. See also
Figure S7.2003), and we asked whether adhesion was more important for
cell survival in inflamed lymph nodes than in homeostatic ones.
Indeed, b1 integrin-blocking antibody had reduced PDPN+ retic-
ular cell survival on day 9 after immunization but not during
homeostasis (Figure 6S). These results suggested that PDPN
during the re-establishment of quiescence maintains a level of
cell-matrix adhesion that permits reticular cell survival.Annexin V binding. The percent of DAPI or 7AAD cells that were Annexin V+ wa
were pooled from three experiments, and there were 1–2 wells per condition per e
changed to serum-free media with goat IgG or anti-LTbR. Live-gated cells were a
numbers, normalized to the goat IgG sample. Each symbol represents one well; d
per experiment. (L) pERM expression. Cells were examined 48 hr after transfectio
levels expressed as a percentage of cells that are pERM+. Each symbol repres
condition per experiment were included.
(M) Effects of Y27632 treatment on cell survival. Left: numbers of DAPI cells. Ri
were pooled from two of four similar experiments, and there were 3–5 wells per
(N) Cell adhesion upon PDPN knockdown, shown as OD at 590 nm. Each symbol
2–3 wells per condition per experiment.
(O) Effect of b1 integrin blockade on cell survival. Left: numbers of DAPI cells. R
were pooled from two experiments, and there were 3–5 wells per condition per e
(P) pFAK (at Y397) expression with PDPN knockdown. Cells were examined 48
cells. Right: pFAK expression. The percent of cells that are pFAK+ was normalized
from three experiments, and there were 2–3 wells per condition per experiment.
(Q) Reticular cell pFAK expression upon Y27632 treatment. Each symbol represen
per condition per experiment.
(R) PDPN+ reticular cell pFAK expression during homeostasis and on day 9 after im
Each symbol represents one mouse; data were pooled from two experiments.
(S) Effect of b1 integrin blockade for 24 hours in vivo. Left: PDPN+ reticular cell
staining in day 9 mice. Each symbol represents one mouse; data are from two (h
*p < .05 and **p < .01 in an unpaired t test comparing treated cells to the indicatSurvival-Factor Supplementation or LTbR Stimulation
Rescues the Immune Response upon DC Depletion
We tested the extent to which the loss of survival factors contrib-
uted to the lymphocyte loss in DC-depleted mice. BAFF rescued
total B and germinal-center B cell numbers (Figure 7A), support-
ing the idea that DC depletion reduced the numbers of BAFF-ex-
pressing mantle-zone reticular cells and FDCs. T cell numberss normalized to control siRNA samples. Each symbol represents one well; data
xperiment. (K) Effects of LTbR stimulation. 48 hr after transfection, media were
nalyzed 24 hr later. Left: PDPN expression in control siRNA samples. Right: cell
ata were pooled from four experiments, and there were 1–3 wells per condition
n. Left: representative flow-cytometry plots of control siRNA cells. Right: pERM
ents one well; data were pooled from two experiments, and 2–3 samples per
ght: Annexin V binding on DAPI cells. Each symbol represents one well; data
condition per experiment.
represents one well; data were pooled from three experiments, and there were
ight: Annexin V binding on DAPI cells. Each symbol represents one well; data
xperiment.
hr after transfection. Left: representative flow-cytometry plot of control siRNA
to control siRNA samples. Each symbol represents one well; data were pooled
ts one well; data were pooled from two experiments, and there were 2–3 wells
munization. Left: representative flow-cytometry plots. Right: pFAK expression.
numbers during homeostasis and on day 9 after immunization. Right: TUNEL
omeostasis) to three (day 9) experiments.
ed controls. Error bars indicate SD. See also Figure S6.
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were also rescued (Figure 7A), perhaps in part reflecting T cell re-
sponses to BAFF (Mackay and Leung, 2006). AFC numbers were
partially rescued (Figure 7B), suggesting roles for additional fac-
tors. IL-7 rescued T cell numbers (Figure 7A), consistent with the
loss of IL-7-expressing T zone reticular cells. IL-7 also rescued
total B cell numbers (Figure 7A), potentially reflecting a role for
IL-7 in the medulla or follicles (Link et al., 2007). BAFF and IL-7
supplementation had similar effects when PDPN was knocked
down (Figure S7A). These results together support the idea that
reduced stromal-derived survival factor, probably in combination
with the loss of DC-derived factors (Mohr et al., 2009), contrib-
uted to the disrupted immune response in DC-depleted mice.
We asked whether preventing reticular cell loss despite
DC depletion could prevent lymphocyte loss. On day 8 after im-
munization, zDC-DTR chimeras were treated with DT and, 5.5–
8 hr later, with control or agonist LTbR antibody. Anti-LTbR
prevented the DT-induced reduced numbers of PDPN+ reticular
cells, B cells, T cells, and germinal-center cells and partially pre-
vented the loss of AFCs (Figures 7C–7E). CD11c+ cell numbers
were modestly increased with anti-LTbR, but the numbers
were still low in comparison to numbers in non-depleted mice
(Figure 7F), suggesting that the effects of anti-LTbR reflected ef-
fects on the stromal compartment and not on LTbR+ CD11c+
cells. Our results together suggest that the stromal disruption
induced by DC depletion played an important role in disrupting
the ongoing immune response and support the idea that a DC-
stromal axis maintains immune responses.
DISCUSSION
Our data suggest a model whereby, upon the re-establishment
of vascular-stromal quiescence, DCs maintain stromal integrity
and, consequently, the ongoing immune response (Figure S7B).
The localization of DCs in all compartments, the co-cultures of
CD11c+ cells and reticular cells, and the in vivo importance of
DC-derived LTbR ligands, which are cell associated (Boulianne
et al., 2012; Lu and Browning, 2014), support the idea that DCs
act locally and directly to maintain reticular cell survival. The
more numerous T and B cells also express LTbR ligands, sug-
gesting scenarios that argue against DCs as direct mediators
of reticular cell survival. One potential scenario is that DC deple-
tion disrupted naive lymphocyte entry (Moussion and Girard,
2011) and that the resulting loss of lymphocyte-derived LTbR
ligands primarily disrupted reticular cell survival. However, DC
depletion during the re-establishment of quiescence activated
endothelial cells and increased lymphocyte entry (data not
shown). Additionally, DC depletion reduced lymphocyte
numbers despite blockade of entry and exit, suggesting that
lymphocyte loss was not primarily due to altered trafficking.
Another possible scenario is that DCs act directly on lympho-
cytes to mediate lymphocyte survival and that the loss of
lymphocyte-derived LTbR ligands upon DC depletion was the
primary cause of reticular cell loss. Although DT treatment
reduced lymph node cellularity of LTb- and LIGHT-deficient
but not WT mixed chimeras (data not shown), T and B cells do
not express LTbR, suggesting that the loss of lymphocytes
was secondary to reticular cell loss. Themost conservative inter-
pretation of our data, then, is that DCs directly maintain reticular
cell survival and that the lymphocyte loss caused by disruption of728 Immunity 42, 719–730, April 21, 2015 ª2015 Elsevier Inc.the DC-stromal axis might amplify reticular cell loss. Resident
DCs are relatively non-motile in comparison to lymphocytes
(Baje´noff et al., 2006), and we speculate that prolonged associ-
ation with reticular cells might allowmore effective delivery of the
membrane-bound signals.
Given the density of DCs in the T zone, a role for DCs in main-
taining T zone function was less unexpected than the role in
supporting follicular function. However, DCs were present in the
follicles, and the high density within the mantle zone at the T-B
boundary suggests the possibility that reticular cells in this region
were among the CXCL13- and BAFF-expressing cells affected
upon DC depletion. DCs more sparsely populated germinal cen-
ters, and these might directly maintain FDCs, which in turn might
maintain germinal-center B cell survival, in part via BAFF. The fact
that DCdepletion reducedFDCnumbers at a proportion similar to
that of other reticular cell subsets suggests that germinal-center
DCs are efficient regulators of FDC survival. Alternatively,
disruption of the mantle zone with DC depletion might have also
contributed to germinal-center disruption given that the reticular
networks in these adjacent compartments are closely situated
(Bannard et al., 2013). In follicles, then, our results suggested
that DCsmaintain total and germinal-center B cell survival at least
in part by maintaining mantle-zone reticular cells and FDCs.
Our results implicate CD11chi DCs as key mediators of retic-
ular cell survival during the re-establishment of quiescence:
these DCs accumulated during this phase and were the
most completely depleted in the zDC-DTR chimeras. This model
whereby late-accumulating CD11chi DCs maintain PDPN
expression and cell survival complements the recently proposed
model whereby early-accumulating MHCIIhi DCs express CLEC-
2 to inhibit PDPN-mediated cell contractility and allow lymph
node growth (Acton et al., 2014; Astarita et al., 2015). However,
our experiments do not rule out roles for other DC populations in
mediating reticular cell survival, and further studies are needed if
we are to understand the roles of each DC subset and the LTbR
ligands each uses.
In addition to identifying a novel DC-LTbR-PDPN-reticular cell
survival axis that supports immune responses, our findings high-
light the idea that reticular cells at homeostasis and in immunized
nodes are in different functional states. Reticular cell survival was
regulated by DCs, PDPN, and cell adhesion only in stimulated
nodes. This raises interesting questions about the drivers and
other consequences of this functional change. These results
also suggest that targeting a DC-stromal axis might allow spe-
cific targeting of inflamed lymph nodes in disease. Lymph nodes
in a chronic lupus model appear to be in a state of re-established
vascular, and presumably stromal, quiescence (Chyou et al.,
2012), suggesting that a DC-stromal axis could maintain autoan-
tibody generation. Such an axis might also exist in lymphoproli-
ferative diseases and in tertiary lymphoid organs (Lambrecht and
Hammad, 2012). Further understanding the role and regulation
of the DC-stromal axis has the potential to lead to new therapeu-
tic approaches for immune diseases.EXPERIMENTAL PROCEDURES
Mice
Mice from 6–14 weeks old were used. C57Bl/6 mice were from The Jackson
Laboratory (JAX), Taconic Farms, National Cancer Institute (NCI), or our own
breeding colony. Congenic CD45.1+ mice were from NCI or our own breeding
colony.Cd11c-DTRmice andRag1/mice originally from JAXwere bred at our
facility and intercrossed to generate Cd11c-DTR Rag1/mice. zDC-DTR mice
(Meredith et al., 2012) were bred at our facility. Ltb/ mice (Koni et al., 1997)
were intercrossed with Rag1/ mice to generate Ltb/ Rag1/ mice in our
facility. Tnfsf14/mice (Zhu et al., 2011) were intercrossedwith Rag1/mice
to generate Tnfsf14/Rag1/ mice at the University of Chicago. All animal
procedures were performed in accordance with the regulations of the Institu-
tional Animal Use and Care Committee at the Hospital for Special Surgery.
Flow-Cytometric Staining of Lymph Node Cells and Calculations
For flow-cytometric staining and analysis, lymph nodes were digested with
type II collagenase (Worthington) prior to antibody staining (Chyou et al., 2011).
For calculations of cells per lymph node for the indicated cell populations,
the percentage of the total gated population was multiplied by the total cell
count per lymph node. For normalized values, the control sample was set to
1, and the value from the experimental sample was normalized accordingly.
For experiments in which there was more than one control sample, the control
values were averaged, and the individual control and experimental samples
were calculated relative to this average value.
Enumeration of Germinal Centers in Tissue Sections
7mmtissue sectionswere collected every five sections through the lymphnode,
and the largest (i.e., middle) five to ten sections were stained for IgD and either
PNA (Vector) or both CD21 and CD35. Identifiable germinal centers (IgD area
that is either CD21+ andCD35+ or PNA+) in each section were counted, and the
maximal number of germinal centers per section was recorded.
Reticular Cell Cultures
PDPN+ reticular cell cultures were generated as described (Benahmed et al.,
2014). In brief, collagenase-digested lymph node cells were cultured for
7–8 days, depleted of CD45+ and CD31+ cells via magnetic selection, and
used directly or passaged one time before use for experiments. SiRNA trans-
fections were performed according to the manufacturer’s instructions for the
Oligofectamine Reagent kit (Invitrogen). For anti-LTbR experiments, at 48 hr
after transfection, the media was changed to serum-free RPMI, and 3 mg/ml
goat IgG or anti-LTbR (R&D Systems) was added. The cells were trypsinized
24 hr later and examined by flow cytometry. For Y27632 and anti-b1 experi-
ments, cells were plated overnight to 80%–90% confluency, and treated
with Y27632 at 10 mM (Acton et al., 2014; Astarita et al., 2015) (Calbiochem-
EMD Millipore) or anti-b1 integrin (HMB1-1) at the indicated concentrations
in serum-free media before being harvested at 48 hours for cell numbers
and annexin V staining or at 24 hours for pFAK staining.
Cell-Adhesion Assay
For tests of cell adhesion, 96-well plates were coated with 20% FBS for 1 hr at
37C. 5,000 reticular cells were added per well in serum-free media and
allowed to adhere for 30 min before fixation and staining with 0.2% crystal vi-
olet in 2% ethanol for 20 min. Bound crystal violet was extracted with 50 ml 1%
SDS, and OD was read at 590 nm.
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